Skip to main content
Elsevier
View Cart

Books in Carcinogenesis

BooksJournals

    • Breast Cancer

      • 1st Edition
      • Volume 2
      • August 25, 1998
      • W.P. Peters + 1 more
      • English
      • Paperback
        9 7 8 0 4 4 4 5 5 1 4 4 3
      • Hardback
        9 7 8 0 7 6 2 3 0 3 8 8 5
      • eBook
        9 7 8 0 0 8 0 5 2 6 4 2 3
      Breast cancer research has never been in such an exciting and hopeful phase as today. From a clinical perspective, the discovery of genetic markers of risk in a proportion of familial breast cancer cases has opened up new vistas for understanding and ultimately preventing this disease. On the other hand, aggressive - even daring - therapies are being proven to be effective against advanced breast cancer. For the breast cancer experimentalist, this is also a time of great advance. Although animal and cell culture breast cancer models have proven to be of great use, there are now increasing opportunities to test the concepts developed in these models in actual clinical samples and cases. It is gratifying to see how well these concepts "translate" into the clinical setting. A very active area of research that is linking the laboratory to the clinic is the dissection of the biology and elucidation of the significance of proliferate breast disease and the identification of true, "high risk" or "preneoplastic" legions within the previously ill-defined spectrum of fibrocystic or benign breast disease. One anticipates that discoveries made here will also lead to earlier detection, intervention and prevention of life-threatening cancer.Even, however, as we look with optimism to the eventual eradication of breast cancer, we are once again forced to face the reality that we have not yet achieved our goal. Thus, we are saddened by the much too premature death of Dr. Helene Smith from breast cancer. Helena's work was at the forefront of efforts to understand the biology of human breast cancer at the molecular level. Her insight, open-mindedness, and refusal to sacrifice relevance for convenience will continue to set the standard for all breast cancer researchers. This volume is dedicated to her memory.

    • The Oncogene and Tumour Suppressor Gene Factsbook

      • 2nd Edition
      • July 11, 1997
      • Robin Hesketh
      • English
      • Paperback
        9 7 8 0 1 2 3 4 4 5 4 8 3
      • eBook
        9 7 8 0 0 8 0 5 3 8 0 0 6
      The Second Edition of The Oncogene and Tumour Suppressor Gene FactsBook has been completely revised, updated, and expanded by 60%. The book contains more than 80 entries on oncogenes including JUN, MYC, and RAS, as well as DNA tumour viruses, tumour suppressor genes, including p53, retinoblastoma, BRCA1, BRCA2, VHL, F2FL, and essential material on angiogenesis and metastasis, apoptosis, cell cycle control, and gene therapy.

    • The Genetics of Cancer

      • 1st Edition
      • June 22, 1997
      • Gajanan V. Sherbet + 1 more
      • English
      • Paperback
        9 7 8 0 1 2 3 9 0 9 4 2 8
      • Hardback
        9 7 8 0 1 2 6 3 9 8 7 5 5
      • eBook
        9 7 8 0 0 8 0 5 4 2 4 8 5
      Written by internationally recognized experts, The Genetics of Cancer provides up-to-date information and insight into the genetic basis of cancer and the mechanisms involved in cancer invasion and its secondary spread. This volume presents the deregulation of the cell cycle in tumor development and integrates the function of tumor suppressor genes, oncogenes, and metastasis-associate... genes in the pathogenesis and progression of cancer. The Genetics of Cancer will be useful to all graduate students, clinicians, and researchers working in the fields of cancer biology, genetics, and molecular biology.

    • Some Aspects of Oncology

      • 1st Edition
      • Volume 1
      • March 25, 1997
      • G. Heppner + 1 more
      • English
      • Hardback
        9 7 8 0 7 6 2 3 0 1 4 6 1
      • Paperback
        9 7 8 0 4 4 4 5 5 1 4 1 2
      • eBook
        9 7 8 0 0 8 0 5 2 6 4 1 6
      The present volume is the first in the advances in oncobiology series. It is meant to be useful not only to clinical and non-clinical oncologists but also to graduate students and medical students. The individual chapters are presented as self-contained summaries of current knowledge rather than as reviews. The last chapter deals with the subject of chemotherapy.

    • Advances in Cancer Research

      • 1st Edition
      • Volume 69
      • August 2, 1996
      • English
      • Hardback
        9 7 8 0 1 2 0 0 6 6 6 9 8
      • Paperback
        9 7 8 0 1 2 3 9 9 3 7 0 0
      • eBook
        9 7 8 0 0 8 0 5 6 2 5 1 3
      This volume of Advances in Cancer Research begins with a "Foundations in Cancer Research" articles by Harold Varmus. He focuses on Andrew Lwoff who influenced a generation of scientists and how Dr. Lwoff's influence on Howard Temlin, in particular, led to the identification of the cause of AIDS. Hiroto Okayama and colleagues discuss the conserved control mechanisms of the G1 and G2 phases in fission yeasts and mammals, and the newly identified control genes. Nilis Mandahl presents the cytogenetic findings in bone and soft tissue tumors and introduces the major molecular genetic findings. Hannel Tapiovaara dn co-workers review plasmin generation at restricted areas of the cell surface and hypothesize that it may be a catalyst for tumor cells to metastasize. Noël Bouck et al. review the evidence suggesting that certain types of stimulations of inducers by activated oncogenes, and decreased production of inhibitors of angiogenesis, may be instrumental in enabling developing tumour cells to attract new cells and continue the malignant growth. Peter L. Stern reviews the role of immunity and the prospects for immune intervention in cervical neoplasia. Lastly, Denis J. Moss and his associates discuss the Epstein-Barr virus (EBV) host-virus relationship and the immune control of EBV infections and examine development of vaccines and immunotherapy.

    • Liver Regeneration and Carcinogenesis

      • 1st Edition
      • September 27, 1995
      • Bozzano G Luisa
      • English
      • Paperback
        9 7 8 0 1 2 3 8 8 6 4 9 1
      • eBook
        9 7 8 0 0 8 0 5 3 5 5 4 8
      Because of its marked capacity to regenerate and the ability of chemical carcinogens and viruses to ready transform hepatocytes, the liver has been used extensively as a model for investigating the molecular mechanisms of cellular proliferation and carcinogenesis. Recently, striking advances have occured in the understanding of hepatocyte growth regulation and the manner in which chemical agents and viruses alter these normal growth regulatory pathways in liver carcinogenesis. This explosion of information has occured in a multitude of researh disciplines. This book brings together current findings in a coherent manner, from a molecular point of view. Three sections cover in detail the areas of liver regeneration, liver carcinogenesis, and liver tumor therapy. The contributors are pioneers and leaders in this field.

    • Genetics of Human Neoplasia, Part A

      • 1st Edition
      • Volume 3
      • September 25, 1995
      • R.S. Verma
      • English
      • Hardback
        9 7 8 1 5 5 9 3 8 8 3 5 1
      • Paperback
        9 7 8 0 4 4 4 5 4 6 6 3 0
      • eBook
        9 7 8 0 0 8 0 5 2 6 1 6 4
      The underlying idea that cancer is a genetic disease at the cellular level was postulated over 75 years ago when Boveri hypothesised that the malignant cell was one that had obtained an abnormal chromatin content. However, it has been only the last decade where enormous strides have been made toward understanding neoplastic development. Explosive growth in the discipline of cancer genetics is so rapid that any attempt to review this subject becomes rapidly outdated and continuous revisions are warranted. Conclusive evidence has been reached associating specific chromosomal abnormalities to various cancers. We have just begun to characterise the genes, which are involved in these consistent chromosomal rearrangements resulting in the elucidation of the mechanisms of neoplastic transformation at a molecular level. The identification of over 50 oncogenes has led to a better understanding of the physiological process. Tumor suppresser genes, which were discovered through inheritance mechanisms, have further shed some light towards understanding the loss of heterozygosity during carcinogenesis. The message emerging with increasing clarity concerning specific pathways which regulate the fundamental process of cell division and uncontrolled growth. The advances in molecular biology have led to a major insight in establishing precise diagnosis and treatment of many cancers resulting in prevention of death. The field is expanding so rapidly that a complete account of all aspects of genetics of cancer could not be accommodated within the scope of a single volume format. Nevertheless, a few very specific topics have been chosen, which readers may find of great interest in hopes that their interest may be rejuvenated concerning the bewildering nature of this deadly disease. The contributors to Volume 3 have provided up-to-date accounts of their fields of expertise. Although the contributors have kept their chapters brief, they include an extensive bibliography for those who wish to understand a particular topic in depth. For more than a century, cancer has been diagnosed on the enigmatic basis of morphological features. Establishing a diagnosis based on DNA, RNA, and proteins, which is done routinely now, was once inconceivable. Cloning a gene of hematopoietic origin is no longer a fantasy. The approach has shifted over the past 15 years from identification of chromosomal abnormalities toward zeroing in on cancer genes.

    • Conjugation-Dependent Carcinogenicity and Toxicity of Foreign Compounds

      • 1st Edition
      • Volume 27
      • May 16, 1994
      • English
      • Hardback
        9 7 8 0 1 2 0 3 2 9 2 7 4
      • Paperback
        9 7 8 0 1 2 3 9 9 4 2 3 3
      • eBook
        9 7 8 0 0 8 0 5 8 1 1 8 7
      Each volume of Advances in Pharmacology provides a rich collection of reviews on timely topics. Emphasis is placed on the molecular basis of drug action, both applied and experimental.Conjuga... reactions have long been associated with the detoxification of xenobiotics. Recent studies suggest that Phase II reactions are an important mechanism for the bioactivation of xenobiotics.This special volume of Advances in Pharmacology features a two-color dust jacket.